Landscapes / Companies
Xilio Development, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
Drugs
2
in active trials · 4 in all
Trials
2 active
4 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | Sep 2028Phase 1/2 trial completes | |||
| Next date | Sep 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1/2 | Nov 2029Phase 1/2 trial completes | |||
| Next date | Nov 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Metastatic NSCLC - Non-Small Cell Lung Cancer, Advanced Solid Tumor | ||||
| Open drug page | |||||
About
- No active trial
- vilastobart, XTX202
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021